Royalty Pharma Increases Bid for Elan
Royalty says it will pay $12.50 in cash for each share of Elan.
-
Business
Featured Story
-
Marketing & Advertising
Featured Story
Glaxo Hit the Most By Drug Price Control Order
HYDERABAD, India, May 20, 2013 (DNA : DAILY NEWS & ANALYSIS (INDIA)) - Consumers may celebrate the new drug price control order (DPCO), which was...
-
R&D
Featured Story
FDA, Peregrine Agree on Phase III Bavituximab Study
Peregrine rises on agreement for late-stage study WASHINGTON (AP) — Shares of Peregrine Pharmaceuticals Inc. surged Monday after the company said it...
-
Therapeutics
Featured Story
Pfizer Halts Study of Non-Hodgkin's Lymphoma Drug
An interim analysis showed the drug wasn't helping patients live longer
-
Pharmalot
Featured Story
Bristol-Myers Is Fined For Monkey Deaths, But Will $2,600 Matter?
In what is apparently an unusual move, the US Department of Agriculture earlier this year fined Bristol-Myers Squibb for violating the Animal Welfare...
- Resources
- Directories
- Manny Awards
- Events
- Jobs